Description
TRELAZ Tablets 50MG (4’s) are a cutting-edge prescription medication available at Gathimaini Pharmacy in Thika, Kenya, designed for the effective and convenient management of Type 2 Diabetes Mellitus. Each tablet contains Trelagliptin 50mg, a dipeptidyl peptidase-4 (DPP-4) inhibitor. Trelagliptin works by enhancing the body’s natural ability to control blood sugar levels; it does this by increasing the levels of incretin hormones which, in turn, stimulate insulin release from the pancreas in a glucose-dependent manner and reduce glucose production by the liver. The distinct advantage of TRELAZ is its once-weekly dosing regimen, significantly improving patient adherence to treatment and providing sustained glycemic control. This makes it an excellent addition to a comprehensive diabetes care plan, alongside diet and exercise.
